{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:48:40Z","timestamp":1774565320447,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,7,15]],"date-time":"2002-07-15T00:00:00Z","timestamp":1026691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1038\/nm733","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:36:31Z","timestamp":1027892191000},"page":"816-824","source":"Crossref","is-referenced-by-count":1527,"title":["Gene-expression profiles predict survival of patients with lung adenocarcinoma"],"prefix":"10.1038","volume":"8","author":[{"given":"David G.","family":"Beer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.R.","family":"Kardia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiang-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert M.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Misek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek G.","family":"Gharib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafydd G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Lizyness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rork","family":"Kuick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy M.G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Iannettoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark B.","family":"Orringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Hanash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,7,15]]},"reference":[{"key":"BFnm733_CR1","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9","volume":"86","author":"WA Fry","year":"1999","unstructured":"Fry, W.A., Phillips, J.L. & Menck, H.R. Ten-year survey of lung cancer treatments and survival in hospitals in the United States. Cancer 86, 1867\u20131876 (1999).","journal-title":"Cancer"},{"key":"BFnm733_CR2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-5223(19)39389-4","volume":"82","author":"DE Williams","year":"1981","unstructured":"Williams, D.E. et al. Survival of patients surgically treated for stage I lung cancer. J. Thorac. Cardiovasc. Surg. 82, 70\u201376 (1981).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnm733_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0003-4975(10)62281-3","volume":"38","author":"PC Pairolero","year":"1984","unstructured":"Pairolero, P.C. et al. Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease. Ann. Thorac. Surg. 38, 331\u2013338 (1984).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnm733_CR4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0022-5223(19)35243-2","volume":"96","author":"T Naruke","year":"1988","unstructured":"Naruke, T. et al. Prognosis and survival in resected carcinoma based on the new international staging system. J. Thorac. Cardiovasc. Surg. 96, 440\u2013447 (1988).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnm733_CR5","first-page":"189","volume":"8","author":"MC Kaisermann","year":"2001","unstructured":"Kaisermann, M.C. et al. Evolving features of lung adenocarcinoma in Rio de Janeiro, Brazil. Oncol. Rep. 8, 189\u2013192 (2001).","journal-title":"Oncol. Rep."},{"key":"BFnm733_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0046-8177(85)80106-4","volume":"16","author":"VL Roggli","year":"1985","unstructured":"Roggli, V.L. et al. Lung cancer heterogeneity: A blinded and randomized study of 100 consecutive cases. Hum. Pathol. 16, 569\u2013579 (1985).","journal-title":"Hum. Pathol."},{"key":"BFnm733_CR7","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/1097-0142(19841101)54:9<1802::AID-CNCR2820540908>3.0.CO;2-4","volume":"54","author":"MH Gail","year":"1984","unstructured":"Gail, M.H. et al. Prognostic factors in patients with resected stage I non-small cell lung cancer: A report from the Lung Cancer Study Group. Cancer 54, 1802\u20131813 (1984).","journal-title":"Cancer"},{"key":"BFnm733_CR8","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/1097-0142(19880515)61:10<2083::AID-CNCR2820611025>3.0.CO;2-U","volume":"61","author":"A Takise","year":"1988","unstructured":"Takise, A. et al. Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer 61, 2083\u20132088 (1988).","journal-title":"Cancer"},{"key":"BFnm733_CR9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5223(19)33744-4","volume":"106","author":"Y Ichinose","year":"1993","unstructured":"Ichinose, Y. et al. Is T factor of the TMN staging system a predominant prognostic factor in pathologic stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 106, 90\u201394 (1993).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnm733_CR10","first-page":"51","volume":"55","author":"DH Harpole","year":"1995","unstructured":"Harpole, D.H. et al. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res. 55, 51\u201356 (1995).","journal-title":"Cancer Res."},{"key":"BFnm733_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJM198710083171504","volume":"317","author":"S Rodenhuis","year":"1987","unstructured":"Rodenhuis, S. et al. Mutational activation of the K-ras oncogene: A possible pathogenic factor in adenocarcinoma of the lung. N. Engl. J. Med. 317, 929\u2013935 (1987).","journal-title":"N. Engl. J. Med."},{"key":"BFnm733_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1056\/NEJM199008303230902","volume":"323","author":"RJC Slebos","year":"1990","unstructured":"Slebos, R.J.C. et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med. 323, 561\u2013565 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnm733_CR13","first-page":"1","volume":"53","author":"Y Horio","year":"1993","unstructured":"Horio, Y. et al. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res. 53, 1\u20134 (1993).","journal-title":"Cancer Res."},{"key":"BFnm733_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1172\/JCI117001","volume":"93","author":"JA Kern","year":"1994","unstructured":"Kern, J.A. et al. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest. 93, 516\u2013520 (1994).","journal-title":"J. Clin. Invest."},{"key":"BFnm733_CR15","first-page":"2496","volume":"54","author":"M Ebina","year":"1994","unstructured":"Ebina, M. et al. Relationship of p53 overexpresson and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res. 54, 2496\u20132503 (1994).","journal-title":"Cancer Res."},{"key":"BFnm733_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3816\/CLC.1999.n.004","volume":"1","author":"SA Mehdi","year":"1997","unstructured":"Mehdi, S.A. et al. Prognostic markers in resected stage I and II non-small cell lung cancer: an analysis of 260 patients with 5 year follow-up. Clin. Lung Cancer 1, 59\u201367 (1997).","journal-title":"Clin. Lung Cancer"},{"key":"BFnm733_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1054\/bjoc.2000.1287","volume":"83","author":"PM Schneider","year":"2000","unstructured":"Schneider, P.M. et al. Multiple molecular marker testing (p53, c-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer. Br. J. Cancer 83, 473\u2013479 (2000).","journal-title":"Br. J. Cancer"},{"key":"BFnm733_CR18","first-page":"790","volume":"6","author":"RS Herbst","year":"2000","unstructured":"Herbst, R.S. et al. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin. Can. Res. 6, 790\u2013797 (2000).","journal-title":"Clin. Can. Res."},{"key":"BFnm733_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/35049567","volume":"1","author":"L Liotta","year":"2000","unstructured":"Liotta, L. & Petricion, E. Molecular profiling of human cancer. Nature Rev. Genet. 1, 48\u201356 (2000).","journal-title":"Nature Rev. Genet."},{"key":"BFnm733_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJM200102223440809","volume":"344","author":"TR Golub","year":"2001","unstructured":"Golub, T.R. Editorial: Genome-wide views of cancer. N. Engl. J. Med. 344, 601\u2013602 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnm733_CR21","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1073\/pnas.191502998","volume":"98","author":"A Bhattacharjee","year":"2001","unstructured":"Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98, 13790\u201313795 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm733_CR22","doi-asserted-by":"publisher","first-page":"13784","DOI":"10.1073\/pnas.241500798","volume":"98","author":"ME Garber","year":"2001","unstructured":"Garber, M.E. et al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 98, 13784\u201313789 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm733_CR23","first-page":"1444","volume":"55","author":"NE Mills","year":"1995","unstructured":"Mills, N.E. et al. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55, 1444\u20131447 (1995).","journal-title":"Cancer Res."},{"key":"BFnm733_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0002-9440(10)62509-6","volume":"159","author":"TJ Giordano","year":"2001","unstructured":"Giordano T.J. et al. Organ-specific molecular classification of lung, colon and ovarian adenocarcinomas using gene expression profiles. Am. J. Pathol. 159, 1231\u20131238 (2001).","journal-title":"Am. J. Pathol."},{"key":"BFnm733_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/75985","volume":"25","author":"DG Albertson","year":"2000","unstructured":"Albertson, D.G. et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet. 25, 144\u2013146 (2000).","journal-title":"Nature Genet."},{"key":"BFnm733_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/1097-0215(20000801)87:3<373::AID-IJC10>3.0.CO;2-X","volume":"87","author":"S Kansra","year":"2000","unstructured":"Kansra, S. et al. IGFBP-3 mediates TGF \u03b21 proliferative response in colon cancer cells. Int. J. Cancer 87, 373\u2013378 (2000).","journal-title":"Int. J. Cancer"},{"key":"BFnm733_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000012052","volume":"57","author":"JV Vadgama","year":"1999","unstructured":"Vadgama J.V. et al. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 57, 330\u2013340 (1999).","journal-title":"Oncology"},{"key":"BFnm733_CR28","first-page":"2607","volume":"15","author":"M Volm","year":"1995","unstructured":"Volm, M., Mattern, J. & Stammler, G. Up-regulation of heat shock protein 70 in adenocarcinoma of the lung in smokers. Anticancer Res. 15, 2607\u20132609 (1995).","journal-title":"Anticancer Res."},{"key":"BFnm733_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/jnci\/85.7.570","volume":"85","author":"DR Ciocca","year":"1993","unstructured":"Ciocca, D.R. et al. Heat shock protein hsp70 in patients with auxillary lymph node-positive breast cancer:prognostic implications. J. Natl. Cancer. Inst. 85, 570\u2013574 (1993).","journal-title":"J. Natl. Cancer. Inst."},{"key":"BFnm733_CR30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/clinchem\/34.4.668","volume":"34","author":"Z Rotenberg","year":"1988","unstructured":"Rotenberg, Z. et al. Total lactate dehydrogenase and its isoenzymes in serum of patients with non-small cell lung cancer. Clin. Chem. 34, 668\u2013670 (1988).","journal-title":"Clin. Chem."},{"key":"BFnm733_CR31","first-page":"318","volume":"45","author":"E Krepela","year":"1998","unstructured":"Krepela, E. et al. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma 45, 318\u2013331 (1998).","journal-title":"Neoplasma"},{"key":"BFnm733_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/172460080001500116","volume":"15","author":"J Kos","year":"2000","unstructured":"Kos, J. et al. Cysteine proteinases and their inhibitors in extracellular fluids: Markers for diagnosis and prognosis in cancer. Int. J. Biol. Markers 15, 84\u201389 (2000).","journal-title":"Int. J. Biol. Markers"},{"key":"BFnm733_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","volume":"286","author":"TR Golub","year":"1999","unstructured":"Golub, T.R. et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286, 531\u2013537 (1999).","journal-title":"Science"},{"key":"BFnm733_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJM200102223440801","volume":"344","author":"I Hedenfalk","year":"2001","unstructured":"Hedenfalk, I. et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539\u2013548 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnm733_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/bjc.1997.505","volume":"76","author":"Y Ohta","year":"1997","unstructured":"Ohta, Y. et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br. J. Cancer. 76, 1041\u20131045 (1997).","journal-title":"Br. J. Cancer."},{"key":"BFnm733_CR36","first-page":"1483","volume":"4","author":"T Shibusa","year":"1998","unstructured":"Shibusa, T., Shijubo, N. & Abe, S. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin. Cancer Res. 4, 1483\u20131487 (1998).","journal-title":"Clin. Cancer Res."},{"key":"BFnm733_CR37","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1093\/emboj\/20.13.3437","volume":"20","author":"SE Girardin","year":"2001","unstructured":"Girardin, S.E. & Yaniv, M. A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation. EMBO J. 20, 3437\u20133446 (2001).","journal-title":"EMBO J."},{"key":"BFnm733_CR38","first-page":"2361","volume":"60","author":"E Liu","year":"2000","unstructured":"Liu, E. et al. The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1. Cancer Res. 60, 2361\u201364 (2000).","journal-title":"Cancer Res."},{"key":"BFnm733_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"BFnm733_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/01902149109064425","volume":"17","author":"LA Hanson","year":"1991","unstructured":"Hanson, L.A. et al. Expression of the glucocorticoid receptor and K-ras genes in urethan-induced mouse lung tumors and transformed cell lines. Exp. Lung. Res. 17, 371\u2013387 (1991).","journal-title":"Exp. Lung. Res."},{"key":"BFnm733_CR41","first-page":"1341","volume":"60","author":"L Lin","year":"2000","unstructured":"Lin, L. et al. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using STS-amplification mapping and quantitative PCR includes the GATA-4 gene. Cancer Res. 60, 1341\u20131347 (2000).","journal-title":"Cancer Res."},{"key":"BFnm733_CR42","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen, J. et al. Tissue microarrays for high throughput molecular profiling of tumor specimens. Nature Med. 4, 844\u2013847 (1998).","journal-title":"Nature Med."},{"key":"BFnm733_CR43","first-page":"543","volume-title":"Applied Multivariate Statistical Analysis","author":"R Johnson","year":"1988","unstructured":"Johnson, R. & Wichern, D.W. Applied Multivariate Statistical Analysis. 543\u2013578 (Prentice Hall, New Jersey, 1988)."},{"key":"BFnm733_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/biomet\/64.1.29","volume":"64","author":"M Stone","year":"1977","unstructured":"Stone, M. Asymptomics for and against cross-validation. Biometrika 64, 29\u201338 (1977).","journal-title":"Biometrika"},{"key":"BFnm733_CR45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox, D.R. Regression models and life tables. J.R. Stat. Soc. 34, 187\u2013220 (1972).","journal-title":"J.R. Stat. Soc."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm733","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T04:26:47Z","timestamp":1733718407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,15]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["BFnm733"],"URL":"https:\/\/doi.org\/10.1038\/nm733","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,15]]}}}